InCred Equities initiated coverage on Artemis Medicare with a 'Buy' rating for a target price of ₹437, anticipating healthy earnings growth driven by additions in operational beds.
Market Samachar is a news aggregator. This article was originally published by Share Market Today. Tap the button above to read the full story on their site.